Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Goodwill: 2010-2017

Historic Goodwill for Altimmune (ALT) over the last 7 years, with Sep 2017 value amounting to $9.3 million.

  • Altimmune's Goodwill rose 297.49% to $9.3 million in Q3 2017 from the same period last year, while for Sep 2017 it was $9.3 million, marking a year-over-year increase of 297.49%. This contributed to the annual value of $18.8 million for FY2016, which is 16.61% down from last year.
  • Latest data reveals that Altimmune reported Goodwill of $9.3 million as of Q3 2017, which was down 73.63% from $35.4 million recorded in Q2 2017.
  • In the past 5 years, Altimmune's Goodwill registered a high of $35.4 million during Q2 2017, and its lowest value of $2.3 million during Q1 2013.
  • Moreover, its 3-year median value for Goodwill was $2.3 million (2017), whereas its average is $9.3 million.
  • Its Goodwill has fluctuated over the past 5 years, first decreased by 16.61% in 2016, then soared by 1,407.33% in 2017.
  • Quarterly analysis of 5 years shows Altimmune's Goodwill stood at $2.3 million in 2013, then remained steady at $2.3 million in 2014, then surged by 857.85% to $22.5 million in 2015, then decreased by 16.61% to $18.8 million in 2016, then spiked by 297.49% to $9.3 million in 2017.
  • Its Goodwill was $9.3 million in Q3 2017, compared to $35.4 million in Q2 2017 and $2.3 million in Q1 2017.